Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C18H17N3O2 |
| Molecular Weight | 307.3465 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=C(C=C1)C2=NN=C(C)N=C2C3=CC=C(OC)C=C3
InChI
InChIKey=HDNJXZZJFPCFHG-UHFFFAOYSA-N
InChI=1S/C18H17N3O2/c1-12-19-17(13-4-8-15(22-2)9-5-13)18(21-20-12)14-6-10-16(23-3)11-7-14/h4-11H,1-3H3
| Molecular Formula | C18H17N3O2 |
| Molecular Weight | 307.3465 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Anitrazafen is a topically effective anti-inflammatory agent. Аpplied topically to guinea-pigs, anitrazafen is a potent anti-inflammatory agent capable both of delaying the onset of and reversing, developing erythema induced by U.V. light. Anitrazafen, following oral administration to rats, showed only slight to moderate activity in the carrageenan-induced paw oedema and adjuvant-induced arthritis tests
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:36:51 GMT 2023
by
admin
on
Fri Dec 15 15:36:51 GMT 2023
|
| Record UNII |
2Y065P7MYR
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C308
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
ANITRAZAFEN
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
2Y065P7MYR
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
336394
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
63119-27-7
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
4748
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
100000086949
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
44410
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
C029087
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
CHEMBL2105947
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
C81668
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
SUB05522MIG
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY | |||
|
DTXSID50212454
Created by
admin on Fri Dec 15 15:36:51 GMT 2023 , Edited by admin on Fri Dec 15 15:36:51 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
